Overview

Detailed Summary

Jubilant Ingrevia is a global player in Specialty Chemicals, CDMO, Nutrition & Health Solutions serving diverse industries. Its diversified product portfolio includes pyridine derivatives, fine chemicals, pharma, and agro intermediates.
The company is prioritizing expansion, evidenced by new plant constructions aimed at boosting production in agrochemical and specialty chemicals sectors. This will support increased demand and strategic growth expectations.
FTAs signed with major regions are anticipated to increase its competitive footing in the US and EU markets, aligning its strategic ambitions with global trade dynamics.
Despite global pricing pressures, the company maintains strong operational resilience, leveraging volume growth and strategic cost optimization to sustain stable performance.
Jubilant Ingrevia is also focusing on emerging segments like semiconductors and AI-applications, positioning itself strategically in high-growth innovation spaces.

Sector: Chemicals
Industry: Chemicals - Speciality - Large
Market Cap: 8,853 Cr
Volatility: High Risk
P/E Ratio: 33.1
Industry P/E: 42.6
PEG Ratio: 1.5
P/B Ratio: 2.9
52W High: 851.85
52W Low: 535.30

Sales CAGR

1Y: 1.01%
3Y: -6.75%
5Y: —
10Y: —

Profit CAGR

1Y: 37.34%
3Y: -16.49%
5Y: —
10Y: —

ROE

TTM: 9.47%
3Y: 8.90%
5Y: 10.03%
10Y: —

ROCE

TTM: 11.15%
3Y: 11.60%
5Y: 13.02%
10Y: —

Technicals

‌

Forecasts

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
PRIVISCL	2840.35	11,130 Cr	36.94	8.98	0.18	21.52	19.32	9.69
JUBLINGREA	554.95	8,853 Cr	33.11	2.91	0.90	9.47	11.15	5.05
CLEAN	740.00	7,887 Cr	32.05	5.26	0.81	17.68	23.61	14.57
ALKYLAMINE	1400.00	7,179 Cr	35.68	4.97	0.71	12.62	16.58	10.22
GALAXYSURF	1940.00	6,882 Cr	24.50	2.71	0.21	11.30	13.56	7.43
DRBECK	8420.00	6,665 Cr	45.17	6.61	0.09	14.66	19.67	12.67
ACI	516.80	6,513 Cr	43.58	3.42	0.57	8.97	11.55	6.01

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	1,020	966	1,074	1,024	1,045	1,057	1,051	1,038	1,121	1,051
Expenses	902	871	983	915	921	918	905	896	985	924
Operating Profit	118	96	91	110	125	138	147	142	136	127
OPM %	11.54	9.89	8.49	10.69	11.91	13.09	13.95	13.69	12.09	12.04
Other Income	8.64	8.81	9.45	9.65	10	9.44	8.39	11	11	-3.64
Interest	13	15	14	14	15	12	14	13	12	12
Depreciation	34	34	36	39	40	40	39	41	41	45
Profit Before Tax	80	55	51	66	80	96	102	100	93	65
Tax %	28.02	29.99	43.04	26.19	26.45	27.41	27.25	24.73	25.19	28.30
Net Profit	57	39	29	49	59	69	74	75	69	47
EPS in Rs	3.64	2.43	1.85	3.08	3.73	4.39	4.64	4.75	4.40	2.97

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.00	684	4,949	4,773	4,136	4,178	4,191
Expenses	0.17	567	4,118	4,226	3,715	3,659	3,640
Operating Profit	-0.17	117	832	547	421	519	552
OPM %	—	17.12	16.81	11.46	10.18	12.43	13.16
Other Income	0.00	-10	31	33	35	38	39
Interest	0.00	7.33	31	22	53	56	54
Depreciation	0.00	22	123	122	136	158	160
Profit Before Tax	-0.17	77	709	437	268	344	377
Tax %	0.00	29.76	32.76	29.59	31.66	26.90	26.45
Net Profit	-0.17	54	477	307	183	251	278
EPS in Rs	—	—	29.97	19.34	11.55	15.84	16.76
Dividend Payout %	0.00	1.69	16.68	25.87	43.29	31.57	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.05	16	16	16	16	16
Reserves	-0.17	1,907	2,417	2,650	2,722	2,911
Borrowings	0.00	556	238	407	740	764
Other Liabilities	0.17	900	1,126	1,186	1,254	1,341
Total Liabilities	0.05	3,379	3,797	4,259	4,732	5,032
Fixed Assets	0.00	1,805	1,798	1,846	2,539	2,581
CWIP	0.00	65	174	525	331	525
Investments	0.00	50	6.19	8.24	15	37
Other Assets	0.05	1,458	1,818	1,880	1,846	1,889
Total Assets	0.05	3,379	3,797	4,259	4,732	5,032

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.00	112	453	462	430	508
Cash from Investing Activity	0.00	33	-71	-469	-568	-389
Cash from Financing Activity	0.05	-72	-418	42	144	-129
Net Cash Flow	0.05	73	-36	35	6.06	-9.43

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	51.57%	51.90%	51.90%	51.90%	51.89%	51.89%	51.87%	51.86%	51.85%	45.55%	45.60%	45.59%
FIIs	7.74%	6.20%	6.35%	6.41%	6.64%	6.60%	7.27%	6.94%	7.17%	7.01%	6.01%	6.20%
DIIs	5.99%	6.79%	9.26%	11.27%	13.72%	14.20%	15.59%	16.11%	16.03%	21.96%	23.25%	24.21%
Public	34.69%	35.11%	32.49%	30.42%	27.75%	27.30%	25.26%	25.09%	24.94%	25.48%	25.14%	24.00%
Total Shareholders	1,85,062	1,86,294	1,73,533	1,62,202	1,50,388	1,42,736	1,25,367	1,24,830	1,20,406	1,23,748	1,25,749	1,17,529

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Available on Pro Plan